ConductScience.org, home

Library / Trial comparisons

Memory Training vs Kundalini Yoga and Meditation: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 1000.0897wilsonClinicalTrials.gov
Risk in group 2000.0876wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20-0.08760.0897newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 2loga group has no participants with the outcomeClinicalTrials.gov
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zeroClinicalTrials.gov
Number needed to harmfrom the risk difference intervalthe two groups' risks are equalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Memory Training
Group memory training will be administered for amnestic mild cognitive impairment (MCI)~Memory Training: Participants will attend a weekly memory training class for 12 weeks as well as receive daily memory homework (12 minute duration) for the 12 weeks.
039EG000ClinicalTrials.gov
Group 2Kundalini Yoga and Meditation
Participants will engage in weekly yoga classes and daily 12 minute meditation~Kundalini yoga and meditation: Participants will participate in a 60 minute yoga and meditation session weekly for 12 weeks and will be assigned a daily Kirtan Kriya meditation (12 minute duration) for 12 weeks.
040EG001ClinicalTrials.gov

Harm 2

FieldValueSource
What it countsTotal, serious adverse eventsClinicalTrials.gov
Time frameAdverse event data were collected from baseline through study completion, up to six months.ClinicalTrials.gov

Trial 8

FieldValueSource
TitleReducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation TrainingClinicalTrials.gov
NCT numberNCT03503669ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsMild Cognitive Impairment, Alzheimer's DiseaseClinicalTrials.gov
InterventionsMemory Training, Kundalini yoga and meditationClinicalTrials.gov
Lead sponsorUniversity of California, Los AngelesClinicalTrials.gov
Results first posted2024-02-08ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT03503669?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.